Market Overview

Benzinga Pro's Top 5 Stocks To Watch For Thurs., Jan. 23, 2020: CODX, LUV, INTC, PAYC, EPZM


Benzinga Pro's Stocks To Watch For Thursday

  • Co-Diagnostics (CODX) - Shares were up 175+% in pre-market action following a company press release which highlighted Co-Diagnostics is designing a test for for the new coronavirus using its CoPrimer platform. The Benzinga Pro Newsdesk compiled a list of 10 more stocks which have been sensitive to coronavirus-related news items: Alpha Pro Tech (APT), Lakeland Industries (LAKE), Vir Biotech (VIR), BioCryst Pharma (BCRX), Inovio (INO), Novavax (NVAX), NanoViricides (NNVC), Cleveland Biolabs (CBLI), Aethlon Medical (AEMD), Cerus (CERS).
  • Southwest Air (LUV) - Reported a Q4 beat. Shares were down 0.7% ahead of the open. Elsewhere in the airline group, American Air (AAL) shares traded higher on a Q4 miss and inline guidance. JetBlue (JBLU) shares were down 0.5% on a Q4 beat but seemingly weak Q1 EPS guidance.
  • Intel (INTC) - Will report Q4 results after the close Thursday. Analysts currently expect EPS of $1.25 on sales of $19.22 billion. Intel earnings have historically been published between 4:01 and 4:05 p.m. ET.
  • Paycom Software (PAYC) - S&P Dow Jones Indices announced the stock will be added to the S&P 500 as of Jan. 28, 2020. Shares were up about 5%.
  • Epizyme (EPZM) - The stock was up 5% ahead of the company's PDUFA meeting of its tazemetostat for epithelioid sarcoma. Results from these meetings are normally heard later in the afternoon. 

Posted-In: Pre-Market Outlook


Related Articles (AAL)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at